Benzimidazole anthelmintic
Albendazole
Binds parasite β-, impairing -dependent glucose uptake and energy metabolism in susceptible helminths.
Primary Mechanism of Action
Clinical / Scientific
Albendazole’s sulphoxide metabolite binds β- in nematodes and cestodes, inhibiting polymerization. Loss of cytoplasmic microtubules reduces glucose uptake and depletes glycogen stores, leading to immobilization and death of susceptible parasites.
Pathway Targets
β-tubulin
Scientific explanation
Inhibition of polymerization in helminths.
Glycolysis
Scientific explanation
Secondary reduction of glucose utilization after disruption.
Pathway Convergence
Clinical / Scientific
Target → pathway → downstream effect → biological consequence. This is a mechanistic map, not a treatment claim.
Parasite energy collapse
Target to downstream effect: β-tubulin binding → Impaired glucose uptake → Glycogen depletion → Immobilization of susceptible helminths
Mechanistically Relevant Repurposed & Adjunctive Applications
Intestinal nematode and cestode infections
EstablishedMechanistic rationale
Widely used anthelmintic for susceptible soil-transmitted helminths and some larval cestode infections, according to labelled indications and local guidelines.
Oncology-related microtubule targeting
PreclinicalMechanistic rationale
Benzimidazole effects have been studied in mammalian cell models; this is not an established anticancer use.
Mechanistic Application Matrix
| Biological Target | Mechanism | Potential Relevance | Evidence Level |
|---|---|---|---|
| β-tubulin | Polymerization inhibition | Helminth cytoskeleton / glucose handling | Established mechanism |
Potential Adjunctive Contexts
Mechanistic complementarity is mainly with other anthelmintic classes that use different parasite targets (for example nicotinic agonists). Combination use is a clinical decision, not a page-level recommendation.
Mechanistic Interaction Considerations
May interact with other hepatically metabolized drugs. Bone-marrow suppression is a labelled concern with prolonged high-exposure regimens. Do not infer unlisted contraindications from this page.
In Plain Language
Albendazole interferes with the protein scaffolding (microtubules) that many worms need to absorb sugar. Without that scaffolding, the parasite cannot keep up its energy supply.
Research Context
- WHO / labelled anthelmintic pharmacology. Established benzimidazole anthelmintic mechanism (β-tubulin).
Compounds Sharing Pathways
Other library compounds whose structured pathway data overlap this ingredient. Shared pathways are not combination recommendations.
β-tubulin
Mechanistic information is provided for scientific and educational purposes. Discussion of biological pathways or investigational applications does not establish clinical efficacy or constitute individualized medical advice.